Bao, Lisha
198  Ergebnisse:
Personensuche X
?
1

Targeting SIGLEC15 as an emerging immunotherapy for anaplas..:

Bao, Lisha ; Li, Ying ; Hu, Xiaoping...
International Immunopharmacology.  133 (2024)  - p. 112102 , 2024
 
?
4

IL2RA+VSIG4+ tumor-associated macrophage is a key subpopula..:

Pan, Zongfu ; Bao, Lisha ; Lu, Xixuan...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1869 (2023)  1 - p. 166591 , 2023
 
?
5

Gut microbiota and autism spectrum disorders: a bidirection..:

Li, Zhi ; Liu, Shuai ; Liu, Fang...
Frontiers in Cellular and Infection Microbiology.  13 (2023)  - p. , 2023
 
?
7

Identification of rare variants causing urea cycle disorder..:

Liu, Fang ; Bao, Li‐sha ; Liang, Ru‐jia...
Journal of Cellular and Molecular Medicine.  25 (2021)  8 - p. 4099-4109 , 2021
 
?
10

Gut microbiota and autism spectrum disorders: a bidirection..:

Li, Zhi ; Liu, Shuai ; Liu, Fang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753022/.  , 2023
 
?
11

The tumor ecosystem in head and neck squamous cell carcinom..:

Gong, Yingying ; Bao, Lisha ; Xu, Tong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077663/.  , 2023
 
?
12

CREB3L1 promotes tumor growth and metastasis of anaplastic ..:

Pan, Zongfu ; Xu, Tong ; Bao, Lisha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531463/.  , 2022
 
?
13

Metabolic Reprogramming of Thyroid Cancer Cells and Crossta..:

Bao, Lisha ; Xu, Tong ; Lu, Xixuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674491/.  , 2021
 
?
14

甲状腺未分化癌免疫治疗的现状及未来:

LU, Xixuan ; BAO, Lisha ; PAN, Zongfu.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931605/.  , 2021
 
?
 
1-15